Marcus Lind
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Education
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes Management and Research 77
- Diabetes Treatment and Management 39
- Diabetes, Cardiovascular Risks, and Lipoproteins 20
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 9
-
- Heart Failure Treatment and Management 9
- Atrial Fibrillation Management and Outcomes 4
- Co-authors
- Ann‐Marie Svensson (27 shared papers)Annika Rosengren (27 shared papers)Aldina Pivodic (24 shared papers)Sofia Dahlqvist (24 shared papers)Hans Wedel (14 shared papers)Soffia Guðbjörnsdóttir (16 shared papers)Mikhail Kosiborod (16 shared papers)Mark Allen Clements (11 shared papers)
- Journals
- Diabetes Care (15 papers)Journal of Diabetes Science and Technology (14 papers)BMJ Open Diabetes Research & Care (10 papers)Diabetes Technology & Therapeutics (9 papers)Primary care diabetes (7 papers)
- Partner nations
- SwedenUnited StatesDenmark
In The Last Decade
Marcus Lind
141 papers receiving 6.2k citations
Marcus Lind's Hit Papers
Peers
Comparison fields: 5 of 107
- Endocrinology, Diabetes and Metabolism 4.4k
- Nephrology 352
- Cardiology and Cardiovascular Medicine 840
- Ophthalmology 130
- Clinical Biochemistry 56
Countries citing papers authored by Marcus Lind
This map shows the geographic impact of Marcus Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Lind more than expected).
Fields of papers citing papers by Marcus Lind
This network shows the impact of papers produced by Marcus Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Lind. The network helps show where Marcus Lind may publish in the future.
Co-authors
The 25 scholars most cited alongside Marcus Lind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 149 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Excess Mortality among Persons with Type 2 Diabetes Hit paper breakdown → | 2015 | 804 |
| 2 | Glycemic Control and Excess Mortality in Type 1 Diabetes Hit paper breakdown → | 2014 | 764 |
| 3 | Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections Hit paper breakdown → | 2017 | 591 |
| 4 | 2011 | 231 | |
| 5 | 2018 | 210 | |
| 6 | A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings Hit paper breakdown → | 2022 | 199 |
| 7 | 2013 | 146 | |
| 8 | 2017 | 142 | |
| 9 | 2021 | 128 | |
| 10 | 2019 | 122 | |
| 11 | 2020 | 114 | |
| 12 | 2018 | 98 | |
| 13 | 2021 | 90 | |
| 14 | 2017 | 86 | |
| 15 | 2012 | 85 | |
| 16 | 2010 | 79 | |
| 17 | 2019 | 75 | |
| 18 | 2014 | 74 | |
| 19 | 2009 | 71 | |
| 20 | 2011 | 67 |
About Marcus Lind
Marcus Lind is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Nephrology, Ophthalmology and Genetics, having authored 149 papers that have together received 6.4k indexed citations. Recurring topics across this work include Diabetes Management and Research (77 papers), Diabetes Treatment and Management (39 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers), Heart Failure Treatment and Management (9 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (9 papers), Chronic Kidney Disease and Diabetes (8 papers), Retinal Diseases and Treatments (7 papers) and Atrial Fibrillation Management and Outcomes (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.4k citations), Nephrology (352 citations), Cardiology and Cardiovascular Medicine (840 citations), Ophthalmology (130 citations) and Clinical Biochemistry (56 citations). Marcus Lind has collaborated with scholars based in Sweden, United States and Denmark. Frequent co-authors include Ann‐Marie Svensson, Annika Rosengren, Aldina Pivodic, Sofia Dahlqvist, Hans Wedel, Soffia Guðbjörnsdóttir, Mikhail Kosiborod, Mark Allen Clements, Arndís Finna Ólafsdóttir and Björn Eliasson. Their work appears in journals such as Diabetes Care, Journal of Diabetes Science and Technology, BMJ Open Diabetes Research & Care, Diabetes Technology & Therapeutics and Primary care diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.